StockTipsArenaBeta

BUY Orchid Pharma Limited — Systematix Shares & Stock

BUYOrchid Pharma Limited
Orchid Pharma share price target & all analyst calls

bySystematix Shares & StockHorizon: NA (inferred 1 year)7 Jul 2026via Economic Times New Stock Recos

Entry₹934Inferred
Target₹1,083
Total upside +15.95% (call closed)
Stop lossNot given
Exit₹1,08314 Jul 2026, 12:07 pm
Target hit+15.95%0.00%upside left
Follow Systematix Shares & Stock for new callsGet alertsWatch ORCHPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 26 Oct, 12:42 am IST
3 supporting6 neutral0 opposing
Supports the BUY call (3)

1 advisor has an active short-term BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·8 Jul · 5d ago

Orchid Pharma Ltd entered into a licensing and supply agreement with Pharmasyntez JSC, Russia.

BSE · Company Update·7 Jul · 6d ago

(opens in new tab)

Orchid Pharma has entered into a licensing and supply agreement with Russia's Pharmasyntez JSC to commercialize its antibiotic Exblifep in Russia. This partnership is expected to generate approximatel

NSE · Press Release·7 Jul · 6d ago

(opens in new tab)
Neutral / worth noting (6)

Orchid Pharma Limited has set July 23, 2026, as the record date for its merger/hive-off.

NSE · Record Date·10 Jul · 3d ago

(opens in new tab)

The Board Meeting of Orchid Pharma Limited noted the effect of the Scheme of Amalgamation.

NSE · Outcome of Board Meeting·10 Jul · 3d ago

(opens in new tab)

Orchid Pharma Limited has provided an update regarding the Scheme of Amalgamation with Dhanuka Laboratories Limited.

BSE · Company Update·10 Jul · 3d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Orchid Pharma

All analyst calls on Orchid Pharma

More from Systematix Shares & Stock

Every call and its outcome